CYROLITE® Advanced Medical Acrylics: Röhm selects IMCD as new authorised distributor for the European Market
Effective April 1, 2020, IMCD N.V., headquartered in Rotterdam (The Netherlands), will be marketing and distributing Röhm’s entire portfolio of acrylic-based CYROLITE® copolymers and CYROLITE® MD products for the medical device and diagnostics markets in Europe except Switzerland and Liechtenstein.
Röhm is a technology leader for polymethyl methacrylate (PMMA) molding compounds. Its CYROLITE® products are designed to meet the stringent requirements of the medical and diagnostic devices and have proven successful in a wide range of applications for over 40 years.
For this new collaboration, Röhm is teaming up with IMCD, a market-leader in the sales, marketing and distribution of speciality chemicals and food ingredients. IMCD provides a dedicated team of technical and commercial experts who work in close relationship with customers across EMEA, while Röhm brings in the reliable manufacturing operations, quality products, and innovative solutions of its medical acrylics portfolio.
CYROLITE® products are transparent, impact-modified thermoplastic molding compounds specially developed for medical technology. These products are the perfect solution for applications requiring superior balance of properties as they are tough, highly transparent, bondable, sterilizable (gamma, e-beam, EtO), easy to process and chemical resistant. All CYROLITE® product grades are BPA free and biocompatible in compliance with USP Class VI and ISO 10993-1. The main applications for these products are in disposable medical device and diagnostics components, such as, infusion and catheter accessories, as well as blood/plasma separators, chest drainage, filters and diagnostics cassettes.
“Our customers will benefit from IMCD’s great service and extended supply chain network. IMCD is a leading distributor that we can count on with excellent knowledge of the market and sales expertise,” says Sergio Corbella, Director Medical Europe within the Business Unit Molding Compounds of Röhm.
Siobhan Bastiansen, Market Manager Medical at IMCD Advanced Materials Group added “We, in the IMCD Medical Polymers Team are delighted to welcome Röhm on board as our new partner. The CYROLITE® products are an excellent fit with our current product portfolio which is offered across Europe. We look forward to promoting these specialty materials to our extensive medical and diagnostic customer base as well as providing a comprehensive service to existing CYROLITE® customers.”
With 3,500 employees and 15 production sites worldwide, Röhm is one of the world’s leading manufacturers in the methacrylate business. The medium-sized company with branches in Germany, China, the USA, Russia, and South Africa has more than 80 years of experience in methacrylate chemistry and a strong technology platform. Our best-known brands include PLEXIGLAS®, ACRYLITE®, DEGALAN® and DEGAROUTE®.
Röhm is a worldwide manufacturer of PMMA products sold under the PLEXIGLAS® and PLEXIMID® trademarks on the European, Asian, African and Australian continents and under the ACRYLITE® and ACRYMID® trademarks in the Americas.
IMCD is a market-leader in the sales, marketing and distribution of specialty chemicals and food ingredients. Its result-driven professionals provide market-focused solutions to suppliers and customers across EMEA, Americas and Asia-Pacific, offering a range of comprehensive product portfolios, including innovative formulations that embrace industry trends. Listed at Euronext, Amsterdam (IMCD), IMCD realised revenues of EUR 2,690 million in 2019 with nearly 3,000 employees in over 50 countries on 6 continents. IMCD's dedicated team of technical and commercial experts work in close partnership to tailor best in class solutions and provide value through expertise for around 49,000 customers and a diverse range of world class suppliers.
More information is available at www.imcdgroup.com